Good question Hotcongo
Given the origins of Trofinetide, I would like to think that scenario could only ever possibly play out if the local NZ Govt agency that negotiates supply arrangements with drug companies for NZ patients, Pharmac, is both chronically underfunded and incompetent ......... unfortunately, this excerpt from a New Zealand Herald article on 1 June 2022 sounds like that's exactly the case (depressingly familiar for those of us living in NZ.....!)
"A patient advocate says a newly-released investigation shows Pharmac needs a major culture overhaul. A review of Pharmac found the drug-buying agency secured some of the best prices possible but had contributed to health inequality for Māori and Pacific peoples. And people with rare disorders faced disproportionately bad health outcomes because of systemic failings, the independent review panel found. Patient advocate Malcolm Mulholland said people who'd lost loved ones after struggling to secure funding for treatment had been awaiting the release of findings. "Pharmac's governance has clearly been asleep at the wheel," he said after reading the panel report. He said the review found Pharmac decision-making had been seriously flawed." It leads you to the question: How many lives have been lost because of this?"
Let's hope that's not the case for Daybue...
- Forums
- ASX - By Stock
- NEU
- Ann: Investor Presentation, 14 March 2023
Ann: Investor Presentation, 14 March 2023, page-31
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 1432 | 13.950 |
2 | 1230 | 13.900 |
1 | 720 | 13.890 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 175 | 1 |
14.500 | 2985 | 2 |
14.800 | 2850 | 2 |
14.860 | 500 | 1 |
14.960 | 445 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |